0001646728-21-000002.txt : 20210125 0001646728-21-000002.hdr.sgml : 20210125 20210125134252 ACCESSION NUMBER: 0001646728-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210125 DATE AS OF CHANGE: 20210125 EFFECTIVENESS DATE: 20210125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Circulogene Theranostics, Inc. CENTRAL INDEX KEY: 0001646728 IRS NUMBER: 473255195 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-387204 FILM NUMBER: 21549198 BUSINESS ADDRESS: STREET 1: 3125 INDEPENDENCE DRIVE STREET 2: SUITE 301 CITY: BIRMINGHAM STATE: AL ZIP: 35209 BUSINESS PHONE: 205-521-8151 MAIL ADDRESS: STREET 1: 3125 INDEPENDENCE DRIVE STREET 2: SUITE 301 CITY: BIRMINGHAM STATE: AL ZIP: 35209 FORMER COMPANY: FORMER CONFORMED NAME: CirculoGene Theranostics, LLC DATE OF NAME CHANGE: 20160415 FORMER COMPANY: FORMER CONFORMED NAME: CirculoGene Diagnostics, LLC DATE OF NAME CHANGE: 20150630 D 1 primary_doc.xml X0708 D LIVE 0001646728 Circulogene Theranostics, Inc. 3125 INDEPENDENCE DRIVE SUITE 301 BIRMINGHAM AL ALABAMA 35209 205-521-8151 DELAWARE CirculoGene Theranostics, LLC CirculoGene Diagnostics, LLC Corporation true Michael V. Mullen 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35203 Executive Officer Director Harold B. Dunn 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Director Daniel B. Coleman 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Director Thomas A. Satterfield 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Director Chen-Hsiung Yeh 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Executive Officer Stephen Eck 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Director Robert Garvie 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Director Scott Rezek 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Executive Officer James E. Cantrell 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Director Charles A. Musial 3125 Independence Drive Suite 301 Birmingham AL ALABAMA 35209 Executive Officer Other Health Care Decline to Disclose 06b false 2021-01-14 false true false 0 Arcadia Securities, LLC 44656 None None 1370 Avenue of the Americas 29th Floor New York NY NEW YORK 10019 AL ALABAMA false 15000000 250000 14750000 false 1 0 17500 true Arcadia is entitled to a fee equal to 7%. The above number equals 7% of the 250,000 sold thus far. Arcadia is also entitled to warrants to purchase 7% of the aggregate shares of capital stock into which the securities sold in the offering convert. 0 The proceeds will go toward general working capital, some of which may be used to pay the salaries of executive officers. false Circulogene Theranostics, Inc. Michael V. Mullen Michael V. Mullen CEO 2021-01-22